Nihon Kohden (NHNKY) 11.4500 $NHNKY
Nihon Kohden Expands Offerings with Award-Winning Defibtech Automated External Defibrillators
Business Wire - Thu Jul 02, 6:00AM CDT
Nihon Kohden today announced it will make the full line of Defibtech automated external defibrillators (AEDs) available through its North American sales network, effective immediately. A sister company of Nihon Kohden America, Defibtech is a leading designer and manufacturer of AEDs that are simple and elegant, yet sophisticated enough to meet the needs of the most demanding first responders across integrated healthcare delivery networks.
Global Neurodiagnostic and Monitoring Devices Market Assessment & Forecast: 2015-2019
M2 - Tue Jun 30, 9:32AM CDT
Research and Markets (http://www.researchandmarkets.com/research/cs359k/global) has announced the addition of the "Global Neurodiagnostic and Monitoring Devices Market Assessment & Forecast: 2015-2019" report to their offering. In terms of geography, North America and Europe are expected to continue leading due to several folds greater level of awareness and research activity in the neurological domain. Asia-Pacific, Middle-East and Latin America will present strong growth riding on the large number of opportunities the emerging economies offer to manufacturers for revenue growth. Emerging countries have invested greatly in healthcare infrastructure and are now shifting focus to research in conventionally low priority areas due to increased awareness of certain diseases such as epilepsy, autism and neurodegenerative diseases to combat their rising incidence across the world. It is estimated that over 20 million people suffer from epilepsy in the Asia-Pacific region. The neurodiagnostic monitoring market has not caught up to its true commercial potential as only clinics and research institutes are relying on major portion of technology. Thus a large number of manufacturers are currently catering only to the neuro-labs and clinics. Diagnostics of irregular episodes of epileptic attacks is a core part of neuromonitoring and the same is not accessible to several thousand patients in the region. According to a report by the WHO on epilepsy in Latin America and Caribbean, ratios of 1.18 neurologists and 0.78 neurosurgeons per 100,000 populations were reported in Latin America and 12 LAC countries reported having 2 physicians with special training in epilepsy (epileptologists). In Asia rising incidence of neurological disorders such as Alzheimer's, Parkinson's, epilepsy among other brain disorders and stroke is expected to fuel growth of monitoring devices in the neurological segment. 2014 estimates suggest that there are over 13 million people suffering from epilepsy and over 75 million people are affected by severe brain disorders. Increasing incidence of head trauma is also believed to influence the growth and adoption of modern life-saving devices. Key Topics Covered: 1. Preface 2. Introduction 3. Market Dynamics 4. Neurodiagnostic and Monitoring Devices - Global Market Size Assessment by Products, Forecast: 2015 - 2019 5. Neurodiagnostic and Monitoring Devices - Global Market Size Assessment, by End-Users, Forecast: 2015 - 2019 6. Neurodiagnostic and Monitoring Devices - Global Market Size Assessment, by Geography, Forecast: 2015 - 2019 7. Key Players Analysis: Global Computed Tomography Systems Market, 2014 (%) 8. Epilogue Companies Mentioned - CTF MEG Technologies - Cadwell Laboratories & Advanced Brain Monitoring - Compumedics - Covidien - Elekta - Nihon Kohden - Tristan Tech - Yokogawa Corporation For more information visit http://www.researchandmarkets.com/research/cs359k/global
Nihon Kohden's Dr. Takuo Aoyagi Receives 2015 IEEE Medal for Innovations in Healthcare Technology
Business Wire - Wed Jun 24, 6:00AM CDT
Nihon Kohden announced today that Senior Manager Dr. Takuo Aoyagi has received the 2015 Institute of Electrical and Electronics Engineers (IEEE) Medal for Innovations in Healthcare Technology. The IEEE is the world's largest technical professional organization dedicated to advancing technology for the benefit of humanity.
Capnography Equipment Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020
M2 - Thu Jun 11, 11:27AM CDT
Research and Markets (http://www.researchandmarkets.com/research/cfsh6z/capnography) has announced the addition of the "Capnography Equipment Market- Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020" report to their offering. This report provides in-depth analysis of the global capnography equipment and disposables market. The stakeholders for this report include companies engaged in the manufacturing and commercialization of capnography equipment, distributors, suppliers, and new entrants, who are planning to invest in the capnography equipment market. A snapshot of this market summarizing the market size, trends, and competition for different types of capnographs and disposables in four major geographies is provided in the executive summary of this report. Geographically, the global capnography equipment market has been categorized into four major regions: North America, Europe, Asia Pacific, and Rest of the World (RoW). Geographic section of the report provides market estimations in terms of revenue (USD million) of the capnography equipment market in these four regions from 2012 to 2020. CAGR % for the period from 2014 to 2020 is also analyzed for these four geographies, considering 2013 as the base year. Companies Mentioned: - Covidien plc - Dragerwerk AG & Co. KGaA - Masimo Corporation - Medtronic, Inc. - Nihon Kohden Corporation - Nonin Medical, Inc. - Philips Healthcare - Smiths Medical - Welch Allyn, Inc. For more information visit http://www.researchandmarkets.com/research/cf...apnography About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
MASI: 38.50 (+0.31), MDT: 74.37 (+1.28)
Halifax Regional Medical Center Enhances Care and Creates Efficiencies with Medical Device Integration from Iatric Systems
Business Wire - Wed Jun 03, 7:05AM CDT
Halifax Regional Medical Center reports streamlined workflows and enhanced patient care after working with Iatric Systems, Inc., a comprehensive healthcare IT integration company, to integrate Welch Allyn and Nihon Kohden medical devices with its electronic health record (EHR) in various hospital areas. With Iatric Systems Accelero Connect(R) in place, patient vital signs are automatically captured and integrated into the medical chart, reducing the chance for transcription errors and further improving patient safety.
Research and Markets: Nihon Kohden Medical Device Company Analysis Report 2015
Business Wire - Tue Jun 02, 12:36PM CDT
Research and Markets (http://www.researchandmarkets.com/research/3sjhd2/nihon_kohden) has announced the addition of the "Nihon Kohden Medical Device Companies Analysis Report " report to their offering.
Nihon Kohden Medical Device Company Analysis Report 2015
M2 - Tue Jun 02, 10:26AM CDT
Research and Markets (http://www.researchandmarkets.com/research/qn8x9t/nihon_kohden) has announced the addition of the "Nihon Kohden Medical Device Companies Analysis Report " report to their offering. The Nihon Kohden Medical Device Company Report provides a full review of the company's medical device activities, from its origins to its latest corporate activity, including mergers and acquisitions, agreements, divestitures and litigation. Sections are also included on products, corporate strategy and R&D. Whatever your interest or involvement, evaluating the performance, success, failures and developments of medical companies is critical. The Medical Device Company Reports have been regularly published for over 20 years, and these critically acclaimed and respected management reports provide a complete review of leading players in the field. Key Benefits: - Evaluate competitive threats - Maximise product and market opportunities - Identify collaborators and strategic partners - Understand the operating market environment - Benchmark your performance against competitors Overview: - Key contact information - Introduction to Nihon Kohden and its current activities - Summary of its financial performance - Key recent events in an at a glance format Strategic Focus: - The company's aims and its areas of focus Financial Review: - Current year and annual financial data, including revenue breakdowns by product area and geographic region (if available) - Table providing in-depth five-year financial analysis - Employee data, including breakdown by company division and geographic location Product Overview: - Core product areas, key brands, product approvals and launches - Identifies the company's major competitors Research and Development: - How much has been invested in R&D? - Where is the research based? - What alliances and agreements does Nihon Kohden have and with whom? Manufacturing and Distribution: - Identifying the company's manufacturing locations - Sales and marketing facilities Agreements: - With whom has Nihon Kohden reached agreements and what do they involve? - Key contracts awarded - Mergers and Acquisitions - Minority Divestments - Litigation - Key Corporate Events For more information visit http://www.researchandmarkets.com/research/qn...hon_kohden
2015 Strategies in the US Point-of-Care/POC Hematology and Flow Cytometry Markets
M2 - Tue Jun 02, 10:05AM CDT
Research and Markets (http://www.researchandmarkets.com/research/nh5j89/2015_strategies) has announced the addition of the "2015 Strategies in the US Point-of-Care/POC Hematology and Flow Cytometry Markets" report to their offering. This new 238-page report contains 38 tables, and provides a comprehensive analysis of the POC hematology and flow cytometry market, including trends, dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and emerging opportunities for instrument and consumable suppliers. This report will help diagnostic product suppliers develop effective business, R&D and marketing strategies for the global POC hematology and flow cytometry market. Companies Mentioned: - Abbott - Agilent Technologies - Beckman Coulter/Danaher - Becton Dickinson - Bio-Rad - Biocode - CellaVision - Diesse Ves Matic - Drew-Scientific - Horiba - Iris - Menarini - Nihon Kohden - Ortho-Clinical Diagnostics - Polymedco - Roche - Siemens - Sysmex For more information visit http://www.researchandmarkets.com/research/nh...strategies
A: 39.40 (+0.48), DHR: 86.65 (+0.91)
2015 Strategies in the US Point-of-Care/POC Coagulation Testing Market
M2 - Thu May 28, 9:56AM CDT
Research and Markets (http://www.researchandmarkets.com/research/x7wr4b/2015_strategies) has announced the addition of the "2015 Strategies in the US Point-of-Care/POC Coagulation Testing Market" report to their offering. This provides a comprehensive analysis of the POC coagulation testing market in the US, including trends, dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and emerging opportunities for instrument and consumable suppliers. This report will help diagnostic product suppliers develop effective business, R&D and marketing strategies for the global POC coagulation market. Companies Mentioned - Abbott - ADI/America Diagnostica - Agilent Technologies - Axis-Shield - Beckman Coulter/Danaher - Becton Dickinson - Bio/Data - Biomerieux - Bio-Rad - Biosite/Inverness/Alere - Cephid - Chrono-Log - Corgenix - Decode - Diadexus - Diagnocure - Diagnostica Stago/Trinity Biotech - Diamedix - Diasorin - Eiken Chemical - EKF Diagnostics - Fujirebio/Innogenetics - Helena Laboratories - Hologic/Gen-Probe - Horiba - Instrumentation Laboratory - International Technidyne/Nexus DX - Kreatech - Kyowa Medex - Life Technologies - Lonza - Mackay Life Sciences - Matritech - Nihon Kohden - Ortho-Clinical Diagnostics - Polartechnics - Polymedco - Qiagen - Roche - SDIX - Sequenom - Siemens - Sienco - Sysmex - Takara Bio - ThermoFisher - Tosoh - Wako - Zycare/Alere For more information visit http://www.researchandmarkets.com/research/x7...strategies
LIFE: 18.36 (+3.03), SQNM: 2.95 (+0.11), A: 39.40 (+0.48), DHR: 86.65 (+0.91), HOLX: 38.71 (+0.75)
Coagulation Analyzer Market Expected to Reach $3.58 Billion by 2019, New Report Says
M2 - Wed May 27, 9:03AM CDT
Research and Markets (http://www.researchandmarkets.com/research/prc6rk/coagulationhemost) has announced the addition of the "Coagulation/Hemostasis Analyzer Market by Product , Consumables, Test Type, Technology, End Users - Forecast to 2019" report to their offering. The global coagulation analyzers market is estimated to grow at a lower CAGR in developed countries; however, it is expected to witness high growth in emerging countries such as China, India, and Brazil in the next five years. Growth in the coagulation analyzers market is driven by factors such as increasing adoption of automated hemostasis instruments by diagnostics laboratories, development of high-throughput hemostasis analyzers, developments in high-sensitivity point-of-care coagulation analyzers, and introduction of technologically advanced hemostasis instruments. However, slow adoption of advanced hemostasis instruments in emerging economies and high cost of hemostasis analyzers are restraining the growth of this market. New product launches and expansions are the key strategies adopted by major players to strengthen their position in the global coagulation analyzer market. Moreover, strategies such as partnerships, agreements, collaborations, joint ventures, and acquisitions were also adopted by a significant number of market players to strengthen their product portfolios and expand their geographic presence. Key Topics Covered 1 Introduction 2 Research Methodology 3 Executive Summary 4 Market Overview 5 Industry Insights 6 Hemostasis/Coagulation Analyzer Market, By Product Type 6.1 Introduction 6.2 Clinical Laboratory Analyzers 6.3 Hemostasis Analyzers for Point-Of-Care Testing 7 Hemostasis/Coagulation Analyzer Market, By Type of Test 7.1 Introduction 7.2 Prothrombin Time (PT/INR) Testing Kits Market 7.3 ACTivated Clotting Time (ACT/APTT) Testing Kits Market 7.4 D Dimer Testing Kits Market 7.5 Fibrinogen Testing Kits Market 7.6 Others Testing Kits Market 8 Hemostasis/Coagulation Analyzer Market, By Technology 8.1 Introduction 8.2 Mechanical 8.3 Optical 8.4 Electrochemical 8.5 Ohers 9 Hemostasis/Coagulation Analyzer Market, By End Users 9.1 Introduction 9.2 Research Institutes 9.3 Diagnostic Laboratories 9.4 Standalone Hospitals 9.5 Other End Users 10 Coagulation Analyzer Market, By Geography 11 Competitive Landscape 12 Company Profile 13 Appendix Companies Mentioned - Alere - Diagnostica Stago - Helena Laboratories - Instrumentation Laboratory Werfen Group - International Technidyne Corporation - Nihon Kohden Corporation (Nihon Kohden) - Roche Diagnostics - Siemens Helathcare - Sysmex Corporation - Thermo Fisher Scientific For more information visit http://www.researchandmarkets.com/research/pr...tionhemost
2015 Strategies in the US Point-of-Care/POC Infectious Disease Testing Market
M2 - Tue May 26, 10:32AM CDT
Research and Markets (http://www.researchandmarkets.com/research/cs5s58/2015_strategies) has announced the addition of the "2015 Strategies in the US Point-of-Care/POC Infectious Disease Testing Market" report to their offering. This new 795-page report contains 61 tables, and provides a comprehensive analysis of the POC infectious disease testing market, including trends, dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and emerging opportunities for instrument and consumable suppliers. This report will help diagnostic product suppliers develop effective business, R&D and marketing strategies for the global POC infectious disease testing market. Companies Mentioned: - ADI/America Diagnostica - Abbott - Agilent Technologies - Becton Dickinson - bioMeriuex - Bio/Data - Biomerieux - Biosite/Inverness/Alere - Cepheid - Diagnostica Stago/Trinity Biotech - Diamedix - Diasorin - EKF Diagnostics - Eiken Chemical - Fujirebio/Innogenetics - Helena Laboratories - Hologic/Gen-Probe - Mackay Life Sciences - Matritech - Nihon Kohden - Ortho-Clinical Diagnostics - Polartechnics - Polymedco - Qiagen - Roche - Siemens - Sienco - Sysmex - Takara Bio - ThermoFisher - Tosoh - Tosoh - Wako - Wallac - Zycare/Alere For more information visit http://www.researchandmarkets.com/research/cs...strategies
A: 39.40 (+0.48), CPHD: 58.15 (+0.75), HOLX: 38.71 (+0.75)
MEA Defibrillators Market Expected To Reach an Estimated Value Of USD 347.8 Million By 2020, Growing at a CAGR of 7.6%
M2 - Fri May 22, 8:55AM CDT
Research and Markets (http://www.researchandmarkets.com/research/jrwr4s/defibrillators) has announced the addition of the "Defibrillators Market - Middle East and Africa Industry Analysis, Size, Volume, Share, Growth, Trends and Forecast 2014 - 2020 " report to their offering. Growing incidences of cardiovascular disease and increasing healthcare infrastructure in the Middle East and Africa are the major factors expected to boost the growth in demand for defibrillators in the region. However, despite an excellent market opportunity in the Middle East and Africa, lack of awareness pertaining to operating of a defibrillator during emergency and unfavorable government intervention to install automated external defibrillators (AEDs) in public places are the key restraints for the growth of market in the Middle East and Africa. Key Topics Covered 1 Introduction 2 Executive Summary 2.1 Market Snapshot: Middle East and Africa Defibrillators Market 3 Market Overview 3.1 Introduction 3.2 Market Dynamics 3.3 Porter's Five Forces Analysis 3.4 Value Chain Analysis 3.5 Regulatory Framework 3.6 Competitive Landscape 3.7 Market Attractiveness Analysis, by Country 4 MEA Defibrillators Market, By Product 4.1 Introduction 4.2 Advanced Life Support (ALS) Defibrillator 4.3 Automated External Defibrillator (AED) 5 MEA Defibrillators Market, By End-user 5.1 Introduction 5.2 Hospital 5.3 Public Access Defibrillation 5.4 Emergency Medical Services 5.5 Business Workplace 6 MEA Defibrillators Market, By Geography 7 Recommendations 7.1 Recommendations - Invest in Public Awareness Programs About Sudden Cardiac Arrest and Defibrillators - Focus on AEDs at Businesses and Workplaces - Continuous Product Development To Ensure Safety And Efficacy 8 Company Profiles Companies Mentioned - HeartSine Technologies - Nihon Kohden - Philips Healthcare - Physio-Control - Schiller - Welch Allyn - Zoll Medical For more information visit http://www.researchandmarkets.com/research/jr...brillators
Nihon Kohden Announces Educational Sessions at National Teaching Institute and Critical Care Exposition
Business Wire - Mon May 18, 11:08AM CDT
As part of its ongoing commitment to education and research, Nihon Kohden, a U.S. market leader in patient monitoring, sleep assessment, neurology and cardiology instrumentation solutions, today announced it will conduct educational sessions for attendees of the American Association of Critical-Care Nurses (AACN) National Teaching Institute (NTI) and Critical Care Exposition, which will be held May 18-21 in San Diego. The three 30-minute sessions, which will be held multiple times May 19-21 at the Nihon Kohden booth, are available free of charge, with attendees earning 0.5 CEU credits for each presentation.
Global Brain Computer Interface Market 2015 - Forecasts to 2020 for the $1.46 Billion Market
M2 - Wed May 13, 8:33AM CDT
Research and Markets (http://www.researchandmarkets.com/research/krhb95/global_brain) has announced the addition of the "Global Brain Computer Interface Market (Type, Application and Geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2013 - 2020" report to their offering. The Global Brain Computer Interface (BCI) market is expected to reach $1.46 billion by 2020, registering a CAGR of 11.5% during 2014-2020 A global rise in the count of brain disorders along with the increasing government funding to improve healthcare systems, would supplement the growth of this market. The non-invasive BCI technology accounted for about 85% of the total BCI market revenue in 2013, and demonstrate a steady growth in future, thus, eliminating the need to perform surgeries and implant BCI devices. Geographically, North America holds a major share in the BCI technology market due to high penetration of such technologies in this region. APAC is also a major contributor primarily to the vast computer gaming industry. The European region constitutes the third largest market and is expected to grow at a relatively higher CAGR during the forecast period. The European Commission is taking active measures for the population with motor disabilities. Key findings of the study: - The Global market for BCI would exhibit a steady growth owing to its increased adoption across key sectors such as healthcare and the gaming industry, during the forecast period (2014 - 2020). - The Invasive BCI technology market would grow at the fastest CAGR of 15.3% during 2014-2020. - Swift growth is expected in the smart home control applications segment due to high living standards in the North American region, especially across U.S. and Canada. - The Asia-Pacific market would foresee tremendous growth for BCI technology systems. The growth is also attributed to the stiff competition amongst the prominent market players leading to swift technological advances in the BCI systems. Players such as Emotiv, Inc., Advanced Brain Monitoring Inc. and Nihon Kohden Corporation are adopting a consistent development process of innovative products to penetrate the market and further enhance the overall revenues. Key Topics Covered: CHAPTER 1 INTRODUCTION CHAPTER 2 EXECUTIVE SUMMARY CHAPTER 3 MARKET OVERVIEW CHAPTER 4 GLOBAL BRAIN COMPUTER INTERFACE MARKET, BY TYPE CHAPTER 5 GLOBAL BRAIN COMPUTER INTERFACE MARKET BY, APPLICATION CHAPTER 6 GLOBAL BRAIN COMPUTER INTERFACE MARKET , BY GEOGRAPHY CHAPTER 7 COMPANY PROFILES - Nihon Kohden Corporation, - Mind Solutions Inc. - Advanced Brain Monitoring, Inc. - Quantum Applied Science and Research, Inc. - Cadwell Laboratories Inc. - OpenBCI - Cortech Solutions, Inc. - Neurosky, Inc - Emotiv, Inc - Guger Technologies OEG For more information visit http://www.researchandmarkets.com/research/kr...obal_brain
European Sleep Apnea Devices Market, by Segment, and Sleep Apnea Therapeutic Devices - Forecast to 2019
M2 - Wed May 06, 6:13AM CDT
Research and Markets (http://www.researchandmarkets.com/research/bjqw72/european_sleep) has announced the addition of the "European Sleep Apnea Devices Market, by Segment (Sleep Apnea Diagnostic Devices (Home Sleep Testing, Respiratory Polygraphs, Actigraphy Systems) and Sleep Apnea Therapeutic Devices (Pap Devices, Oxygen Devices, Airway Clearance Systems)-Forecast to 2019" report to their offering. The European sleep apnea devices market is projected to grow at a CAGR of 16.0% from 2014 to 2019 Germany holds the largest share of the European sleep apnea devices market. This large share of the German segment is attributed to the various driving forces, such as the increasing prevalence of sleep disorders in this region, increasing awareness level among patients and caregivers, rising number of cases of cardiovascular disorders, and the availability of technologically advanced diagnostic and therapeutic devices. However, the inadequate reimbursement coverage and patient compliance are perceived to hinder the growth of this market in the coming years. The high costs associated with the diagnosis and treatment of sleep apnea also restrains the growth of devices market in this region. The research report classifies the European sleep apnea devices market on the basis of segment into sleep apnea therapeutic devices and sleep apnea diagnostic devices. The sleep apnea therapeutic devices is further segmented based on types into home sleep testing/portable monitoring, sleep labs, respiratory polygraphs, two channel screening devices, single channel screening devices, and actigraphy systems. Similarly, the sleep apnea therapeutic devices market is segmented based on the types into Positive Airway Pressure (PAP) devices, masks, adaptive servo-ventilation, airway clearance systems, oxygen devices, and oral appliances. The PAP devices segment is the largest contributor in the therapeutic devices market. Moreover, the therapeutic devices segment is the largest contributor to the overall European sleep apnea devices market, having accounted for a share of 58.1% in 2014. Further, the European sleep apnea devices market is segmented based on the major countries of the region, such as Germany, France, the U.K., Italy, Spain, and the Rest of Europe (RoE). Germany is the largest market for sleep apnea devices in Europe. It accounted for a share of 27.9% of the European sleep apnea devices market in 2014. The major factors contributing to its dominance are the increasing prevalence of sleep disorders, rising awareness among patients and caregivers, and availability of advanced diagnosis and therapy options. France is the second-largest market in Europe and is projected to grow at a CAGR of 16.6% from 2014 to 2019. The U.K. houses the fastest-growing segment of the European sleep apnea devices market, and is projected to grow at the fastest CAGR from 2014 to 2019. The rising research & development activities pertaining to sleep disorders, rising obesity rates, and increasing awareness levels among patients and caregivers, are some of the factors expected to drive the growth of the European sleep apnea devices market in the coming years. Companies Mentioned - Ambulatory Monitoring, Inc. - BMC Medical Co., Ltd. - Carefusion Corporation - Compumedics Limited - Devilbiss Healthcare - Fisher and Paykel Healthcare Ltd. - Itamar Medical, Ltd. - Natus Medical, Inc. - Nihon Kohden - Nonin Medical - Philips Respironics (Subsidiary of Philips Healthcare Ltd.) - Resmed, Inc. - Somnomedics Gmbh - Weinmann Medical Devices Gmbh & Co. Kg For more information visit http://www.researchandmarkets.com/research/bj...pean_sleep
BABY: 42.30 (+1.11)
North American Automated External Defibrillator (AED) Market 2015 - Forecast to 2019 for Semi-Automated External Defibrillators and Fully-Automated External Defibrillators
M2 - Wed Apr 29, 10:30AM CDT
Research and Markets (http://www.researchandmarkets.com/research/3mpnvr/north_american) has announced the addition of the "North American Automated External Defibrillator (AED) Market by Product, by End-User - Forecast to 2019" report to their offering. The North American automated external defibrillator (AED) market is estimated to grow at a CAGR of 6.8% from 2014 to 2019. The U.S. held a larger share of the automated external defibrillator (AED) market with about 89.9% in 2013, followed by Canada. The North American automated external defibrillator (AED) market holds high potential for growth in future, due to a number of forces that favor this market. These include the rising incidences of cardiovascular diseases and sudden cardiac arrest (SCA), increasing awareness of SCA and the life-saving potential of AEDs, and an implementation of public access defibrillation programs in various countries. In this report, the North American automated external defibrillator (AED) market is broadly classified on the basis of product types, pricing of the equipment, and end-users. The products segment is classified into semi-automated external defibrillators and fully-automated external defibrillators. Based on end-users, the automated external defibrillator (AED) market is categorized into public facilities, hospitals, pre-hospitals, homecare & nursing homes, and others. Geographically, the market is divided into two countries, namely the U.S. and Canada. The U.S. is estimated to command the largest share of 89.9% of the North American automated external defibrillator (AED) market in 2013, followed by Canada. Canada is estimated to grow at a CAGR of 6.8% from 2014 to 2019. The U.S. forms the largest market for AEDs with about 200,000 units sold annually for public use. Strong competition in the U.S. market has brought about a significant decrease in AED costs. Following the enforcement of federal law that necessitates the installation of public access defibrillators (PAD), a large number of AEDs have been installed at public places in the U.S., resulting in growth in this region. The report has profiled the leading players of this market along with their developments (new product launches & partnerships, agreements, collaborations, and joint ventures) over the past few years and strategies adopted by them to sustain and strengthen their position in the North American automated external defibrillator (AED) market. Philips Healthcare (the Netherlands), Cardiac Science Corporation (U.S.), ZOLL Medical Corporation (U.S.), Physio-Control, Inc. (U.S.), NIHON KOHDEN CORPORATION (Japan), Defibtech, LLC (U.S.), and HeartSine Technologies, Inc. (U.S.) are some of the key players engaged in this market. For more information visit http://www.researchandmarkets.com/research/3m...h_american
Sleep Apnea Devices Market by Segments (Sleep Apnea Therapeutic Devices, Sleep Apnea Diagnostic Devices) - Global Forecast to 2019
M2 - Thu Apr 23, 9:08AM CDT
Research and Markets (http://www.researchandmarkets.com/research/lnxd5m/sleep_apnea) has announced the addition of the "Sleep Apnea Devices Market by Segments (Sleep Apnea Therapeutic Devices, Sleep Apnea Diagnostic Devices) - Global Forecast to 2019" report to their offering. The global sleep apnea devices market is expected to grow at a CAGR of 16.6% during the forecast period of 2014 to 2019. North America is the largest market in the global sleep apnea devices market, with a market share of 51.8% as of 2013, followed by Europe and Asia. The largest share of the North American segment is associated with various driving forces, such as the increasing patient pool of sleep apnea in this region, increasing awareness level among patients and caregivers, and the availability of technologically advanced diagnostic and therapeutic devices. It is estimated that approximately 4% of men and 2% of women suffer from Obstructive Sleep Apnea (OSA) globally. Also, the rising prevalence of comorbidities (such as drug-resistant hypertension, congestive heart failure, Type 2 diabetes, and stroke, among others) ensures that the global sleep apnea patient pool will grow in the coming years. However, the inadequate reimbursement coverage and patient compliance are perceived to hinder the growth of this market during the forecast period, 2014 to 2019. In this report, the global sleep apnea devices market is broadly classified on the basis of segments, namely sleep apnea therapeutic devices and sleep apnea diagnostic devices. The sleep apnea therapeutic devices is further segmented based on types, into home sleep testing/portable monitoring, sleep labs, respiratory polygraphs, two-channel screening devices, single channel screening devices, and actigraphy systems. Similarly, the sleep apnea therapeutic devices market is segmented based on types, into Positive Airway Pressure (PAP) devices, masks, adaptive servo-ventilation, airway clearance systems, oxygen devices, and oral appliances. PAP devices segment is the highest contributor in the therapeutic devices market. Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Market Overview 5 Global Sleep Apnea Devices Market, By Type 6 Global Sleep Apnea Market, By Geography 7 Global Sleep Apnea Devices Market: Competitive Landscape 8 Sleep Apnea Devices Market, By Company - Advanced Brain Monitoring,Inc., - Ambulatory Monitoring, Inc. - Bmc Medical Co., Ltd. - Cadwell Laboratories, Inc. - Carefusion Corporation - Clevemed - Compumedics Limited - Fisher And Paykel Healthcare Ltd. - Itamar Medical, Ltd. - Natus Medical, Inc. - Nihon Kohden - Nonin Medical - Novasom - Philips Respironics (Subsidiary Of Philips Healthcare Ltd.) - Resmed, Inc. - Weinmann Medical Devices Gmbh & Co. Kg For more information visit http://www.researchandmarkets.com/research/ln...leep_apnea
BABY: 42.30 (+1.11)
Global Defibrillators Market 2015-2019 - Implantable Cardioverter Defibrillator (Single & Dual Chamber, CRT-D, & S-ICD) and External (Monitor/Defibrillator, AED, & Wearable)
M2 - Mon Apr 20, 4:12AM CDT
Research and Markets (http://www.researchandmarkets.com/research/w4vpdf/defibrillators) has announced the addition of the "Defibrillators Market by Product (Implantable Cardioverter Defibrillator (Single & Dual Chamber, CRT-D, & S-ICD) and External (Monitor/Defibrillator, AED, & Wearable)), by End User (Hospital, Pre-hospital, Public Access, & Home) - Global Forecast to 2019" report to their offering. The global defibrillator market is estimated to grow $12.9 billion by 2019, at a CAGR of 6.9% from 2014 to 2019. Factors such as development of technologically advanced defibrillator, rapid growth in aging population with high risk of target diseases, rising incidences of cardiovascular disease, growing focus of public and private organizations and key market players toward public access defibrillator, and increasing number of training and awareness programs across the globe are propelling the growth of the market. However, lack of awareness about sudden cardiac arrest, issues related to the use of defibrillator devices (external and implantable), and unfavorable healthcare reforms in the U.S. are restraining the growth of this market. In addition to this, the increasing pricing pressure on market players and frequent product recalls are the key challenges faced by market players in the market. On the basis of regions, this market is classified into North America, Europe, Asia-Pacific, and Rest of the World. In 2014, North America is expected to dominate the global defibrillators market. Growth of this region can be attributed to the technological advancements and product innovations, increasing number of public defibrillation programs, rising prevalence of obesity, and rising focus of key players to expand their business in the North American region. However, the Asia-Pacific market is expected to grow at the highest CAGR from 2014 to 2019, due to factors such as rapidly increasing aging population, growing focus of multinational companies on emerging markets, improving and modernizing healthcare infrastructure, and huge burden of cardiovascular disease in this region. Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Premium Insights 5 Market Overview 6 Industry Trends 7 Global Defibrillators Market, By Product 8 Global Defibrillators Market, By End User 9 Defibrillator Market, By Region 10 Competitive Landscape 11 Company Profiles - Biotronik Se & Co.KG - Boston Scientific Corporation - Cardiac Science Corporation (A Subsidiary of Opto Circuits India Limited) - Heartsine Technologies, Inc. - Medtronic, Inc. - Nihon Kohden Corporation - Philips Healthcare (A Division of Koninklijke Philips N.V.) - Physio-Control, Inc. - ST. Jude Medical, Inc. - Sorin Group - Zoll Medical Corporation (A Subsidiary of Asahi Kasei Corporation) For more information visit http://www.researchandmarkets.com/research/w4...brillators
BSX: 17.60 (+0.15), MDT: 74.37 (+1.28), STJ: 75.33 (+0.79)
Global Sleep Apnea Diagnostic and Therapeutic Devices Market 2015-2019
M2 - Wed Apr 15, 4:23AM CDT
Research and Markets (http://www.researchandmarkets.com/research/8w259s/global_sleep) has announced the addition of the "Global Sleep Apnea Diagnostic and Therapeutic Devices Market 2015-2019" report to their offering. The Global Sleep Apnea Diagnostic and Therapeutic Devices market to grow at a CAGR of 8.16 percent over the period 2014-2019. Sleep apnea is a common sleeping disorder that breaks breath many times during sleep. OSA is the common type of sleep apnea, and it causes snoring, when the soft tissue in the back of the throat relaxes during sleep and blocks the airway. Sleep apnea symptoms includes morning headaches, waking up frequently to urinate, and dry mouth and sore in the morning. Sleep apnea diagnostic devices such PSG, actigraphy systems, and pulse oximeters are used for the screening of sleep apnea, while positive airway pressure and oral appliances are used for sleep apnea therapy. High adoption of home diagnostics for diagnosis of sleep apnea is a key trend ibn this market. Home diagnostics are convenient and cost-effective when compared to in-lab sleep tests and therefore are expected to propel the market growth. According to the report, high prevalence of sleep apnea disorder in people worldwide is a major driver in the market. The disorder is common in both adults and children and can result in hypertension, stroke, type II diabetes or adult onset diabetes, weight gain, impotence and cardiovascular diseases. Further, the report states that lack of patient compliance is a key challenges in the market. Discomfort coupled with nosebleeds, anxiety, appliance leaking, claustrophobia and nasal stuffiness contribute to non-compliance when using CPAP or BiPAP devices. Key Vendors - Fisher & Paykel Healthcare - Philips Healthcare - ResMed Other Prominent Vendors - Apnex Medical - Briggs Healthcare - Bunnell - Cadwell Laboratories - Carefusion - Clement Clarke International - Cleveland Medical Devices - Compumedics - Dehaier Medical Systems - DeVilbiss Healthcare - Drager Medical - Embla Systems - GE Healthcare - Hamilton Medical - ImThera Medical - Invacare Corporation - Itamar Medical - Natus Medical - Nihon Kohden - Salter Labs - Teleflex Medical - Ventus Medical - Weinmann Gerate fur Medizin - Zephyr Sleep Technologies Key Topics Covered: - Executive Summary - List of Abbreviations - Scope of the Report - Market Research Methodology - Introduction - Types of Sleep Apnea - Disease Linked with the Sleep Apnea - Symptoms Associated with Sleep Apnea - Market Landscape - Global Sleep Apnea Diagnostic and Therapeutic Devices Market - Geographical Segmentation - Buying Criteria - Market Growth Drivers - Drivers and their Impact - Market Challenges - Impact of Drivers and Challenges - Market Trends - Trends and their Impact - Vendor Landscape - Key Vendor Analysis For more information visit http://www.researchandmarkets.com/research/8w...obal_sleep
BABY: 42.30 (+1.11), DHRM: 2.01 (unch), IVC: 20.62 (+0.25)
Nihon Kohden Names Dr. Wilson Constantine CEO of North America
Business Wire - Tue Apr 14, 6:00AM CDT
Nihon Kohden, a U.S. market leader in patient monitoring, sleep assessment, neurology and cardiology instrumentation solutions, has appointed Dr. Wilson P. Constantine the new chief executive officer of Nihon Kohden America. Constantine, who joined the company's U.S. operations as chief operating officer in September 2014, was named CEO as part of a reorganization that will allow the company to remain ahead of the needs of the rapidly changing U.S. healthcare market. He succeeds Fumio Izumida, who led the company through solid double digit growth between 2010 and 2015.
Nihon Kohden Expands Offerings with Award-Winning Defibtech Automated External Defibrillators
Business Wire - Thu Jul 02, 6:00AM CDT
Nihon Kohden today announced it will make the full line of Defibtech automated external defibrillators (AEDs) available through its North American sales network, effective immediately. A sister company of Nihon Kohden America, Defibtech is a leading designer and manufacturer of AEDs that are simple and elegant, yet sophisticated enough to meet the needs of the most demanding first responders across integrated healthcare delivery networks.
Global Neurodiagnostic and Monitoring Devices Market Assessment & Forecast: 2015-2019
M2 - Tue Jun 30, 9:32AM CDT
Research and Markets (http://www.researchandmarkets.com/research/cs359k/global) has announced the addition of the "Global Neurodiagnostic and Monitoring Devices Market Assessment & Forecast: 2015-2019" report to their offering. In terms of geography, North America and Europe are expected to continue leading due to several folds greater level of awareness and research activity in the neurological domain. Asia-Pacific, Middle-East and Latin America will present strong growth riding on the large number of opportunities the emerging economies offer to manufacturers for revenue growth. Emerging countries have invested greatly in healthcare infrastructure and are now shifting focus to research in conventionally low priority areas due to increased awareness of certain diseases such as epilepsy, autism and neurodegenerative diseases to combat their rising incidence across the world. It is estimated that over 20 million people suffer from epilepsy in the Asia-Pacific region. The neurodiagnostic monitoring market has not caught up to its true commercial potential as only clinics and research institutes are relying on major portion of technology. Thus a large number of manufacturers are currently catering only to the neuro-labs and clinics. Diagnostics of irregular episodes of epileptic attacks is a core part of neuromonitoring and the same is not accessible to several thousand patients in the region. According to a report by the WHO on epilepsy in Latin America and Caribbean, ratios of 1.18 neurologists and 0.78 neurosurgeons per 100,000 populations were reported in Latin America and 12 LAC countries reported having 2 physicians with special training in epilepsy (epileptologists). In Asia rising incidence of neurological disorders such as Alzheimer's, Parkinson's, epilepsy among other brain disorders and stroke is expected to fuel growth of monitoring devices in the neurological segment. 2014 estimates suggest that there are over 13 million people suffering from epilepsy and over 75 million people are affected by severe brain disorders. Increasing incidence of head trauma is also believed to influence the growth and adoption of modern life-saving devices. Key Topics Covered: 1. Preface 2. Introduction 3. Market Dynamics 4. Neurodiagnostic and Monitoring Devices - Global Market Size Assessment by Products, Forecast: 2015 - 2019 5. Neurodiagnostic and Monitoring Devices - Global Market Size Assessment, by End-Users, Forecast: 2015 - 2019 6. Neurodiagnostic and Monitoring Devices - Global Market Size Assessment, by Geography, Forecast: 2015 - 2019 7. Key Players Analysis: Global Computed Tomography Systems Market, 2014 (%) 8. Epilogue Companies Mentioned - CTF MEG Technologies - Cadwell Laboratories & Advanced Brain Monitoring - Compumedics - Covidien - Elekta - Nihon Kohden - Tristan Tech - Yokogawa Corporation For more information visit http://www.researchandmarkets.com/research/cs359k/global
Nihon Kohden's Dr. Takuo Aoyagi Receives 2015 IEEE Medal for Innovations in Healthcare Technology
Business Wire - Wed Jun 24, 6:00AM CDT
Nihon Kohden announced today that Senior Manager Dr. Takuo Aoyagi has received the 2015 Institute of Electrical and Electronics Engineers (IEEE) Medal for Innovations in Healthcare Technology. The IEEE is the world's largest technical professional organization dedicated to advancing technology for the benefit of humanity.
Capnography Equipment Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020
M2 - Thu Jun 11, 11:27AM CDT
Research and Markets (http://www.researchandmarkets.com/research/cfsh6z/capnography) has announced the addition of the "Capnography Equipment Market- Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020" report to their offering. This report provides in-depth analysis of the global capnography equipment and disposables market. The stakeholders for this report include companies engaged in the manufacturing and commercialization of capnography equipment, distributors, suppliers, and new entrants, who are planning to invest in the capnography equipment market. A snapshot of this market summarizing the market size, trends, and competition for different types of capnographs and disposables in four major geographies is provided in the executive summary of this report. Geographically, the global capnography equipment market has been categorized into four major regions: North America, Europe, Asia Pacific, and Rest of the World (RoW). Geographic section of the report provides market estimations in terms of revenue (USD million) of the capnography equipment market in these four regions from 2012 to 2020. CAGR % for the period from 2014 to 2020 is also analyzed for these four geographies, considering 2013 as the base year. Companies Mentioned: - Covidien plc - Dragerwerk AG & Co. KGaA - Masimo Corporation - Medtronic, Inc. - Nihon Kohden Corporation - Nonin Medical, Inc. - Philips Healthcare - Smiths Medical - Welch Allyn, Inc. For more information visit http://www.researchandmarkets.com/research/cf...apnography About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
MASI: 38.50 (+0.31), MDT: 74.37 (+1.28)
Halifax Regional Medical Center Enhances Care and Creates Efficiencies with Medical Device Integration from Iatric Systems
Business Wire - Wed Jun 03, 7:05AM CDT
Halifax Regional Medical Center reports streamlined workflows and enhanced patient care after working with Iatric Systems, Inc., a comprehensive healthcare IT integration company, to integrate Welch Allyn and Nihon Kohden medical devices with its electronic health record (EHR) in various hospital areas. With Iatric Systems Accelero Connect(R) in place, patient vital signs are automatically captured and integrated into the medical chart, reducing the chance for transcription errors and further improving patient safety.
Research and Markets: Nihon Kohden Medical Device Company Analysis Report 2015
Business Wire - Tue Jun 02, 12:36PM CDT
Research and Markets (http://www.researchandmarkets.com/research/3sjhd2/nihon_kohden) has announced the addition of the "Nihon Kohden Medical Device Companies Analysis Report " report to their offering.
Nihon Kohden Medical Device Company Analysis Report 2015
M2 - Tue Jun 02, 10:26AM CDT
Research and Markets (http://www.researchandmarkets.com/research/qn8x9t/nihon_kohden) has announced the addition of the "Nihon Kohden Medical Device Companies Analysis Report " report to their offering. The Nihon Kohden Medical Device Company Report provides a full review of the company's medical device activities, from its origins to its latest corporate activity, including mergers and acquisitions, agreements, divestitures and litigation. Sections are also included on products, corporate strategy and R&D. Whatever your interest or involvement, evaluating the performance, success, failures and developments of medical companies is critical. The Medical Device Company Reports have been regularly published for over 20 years, and these critically acclaimed and respected management reports provide a complete review of leading players in the field. Key Benefits: - Evaluate competitive threats - Maximise product and market opportunities - Identify collaborators and strategic partners - Understand the operating market environment - Benchmark your performance against competitors Overview: - Key contact information - Introduction to Nihon Kohden and its current activities - Summary of its financial performance - Key recent events in an at a glance format Strategic Focus: - The company's aims and its areas of focus Financial Review: - Current year and annual financial data, including revenue breakdowns by product area and geographic region (if available) - Table providing in-depth five-year financial analysis - Employee data, including breakdown by company division and geographic location Product Overview: - Core product areas, key brands, product approvals and launches - Identifies the company's major competitors Research and Development: - How much has been invested in R&D? - Where is the research based? - What alliances and agreements does Nihon Kohden have and with whom? Manufacturing and Distribution: - Identifying the company's manufacturing locations - Sales and marketing facilities Agreements: - With whom has Nihon Kohden reached agreements and what do they involve? - Key contracts awarded - Mergers and Acquisitions - Minority Divestments - Litigation - Key Corporate Events For more information visit http://www.researchandmarkets.com/research/qn...hon_kohden
2015 Strategies in the US Point-of-Care/POC Hematology and Flow Cytometry Markets
M2 - Tue Jun 02, 10:05AM CDT
Research and Markets (http://www.researchandmarkets.com/research/nh5j89/2015_strategies) has announced the addition of the "2015 Strategies in the US Point-of-Care/POC Hematology and Flow Cytometry Markets" report to their offering. This new 238-page report contains 38 tables, and provides a comprehensive analysis of the POC hematology and flow cytometry market, including trends, dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and emerging opportunities for instrument and consumable suppliers. This report will help diagnostic product suppliers develop effective business, R&D and marketing strategies for the global POC hematology and flow cytometry market. Companies Mentioned: - Abbott - Agilent Technologies - Beckman Coulter/Danaher - Becton Dickinson - Bio-Rad - Biocode - CellaVision - Diesse Ves Matic - Drew-Scientific - Horiba - Iris - Menarini - Nihon Kohden - Ortho-Clinical Diagnostics - Polymedco - Roche - Siemens - Sysmex For more information visit http://www.researchandmarkets.com/research/nh...strategies
A: 39.40 (+0.48), DHR: 86.65 (+0.91)
2015 Strategies in the US Point-of-Care/POC Coagulation Testing Market
M2 - Thu May 28, 9:56AM CDT
Research and Markets (http://www.researchandmarkets.com/research/x7wr4b/2015_strategies) has announced the addition of the "2015 Strategies in the US Point-of-Care/POC Coagulation Testing Market" report to their offering. This provides a comprehensive analysis of the POC coagulation testing market in the US, including trends, dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and emerging opportunities for instrument and consumable suppliers. This report will help diagnostic product suppliers develop effective business, R&D and marketing strategies for the global POC coagulation market. Companies Mentioned - Abbott - ADI/America Diagnostica - Agilent Technologies - Axis-Shield - Beckman Coulter/Danaher - Becton Dickinson - Bio/Data - Biomerieux - Bio-Rad - Biosite/Inverness/Alere - Cephid - Chrono-Log - Corgenix - Decode - Diadexus - Diagnocure - Diagnostica Stago/Trinity Biotech - Diamedix - Diasorin - Eiken Chemical - EKF Diagnostics - Fujirebio/Innogenetics - Helena Laboratories - Hologic/Gen-Probe - Horiba - Instrumentation Laboratory - International Technidyne/Nexus DX - Kreatech - Kyowa Medex - Life Technologies - Lonza - Mackay Life Sciences - Matritech - Nihon Kohden - Ortho-Clinical Diagnostics - Polartechnics - Polymedco - Qiagen - Roche - SDIX - Sequenom - Siemens - Sienco - Sysmex - Takara Bio - ThermoFisher - Tosoh - Wako - Zycare/Alere For more information visit http://www.researchandmarkets.com/research/x7...strategies
LIFE: 18.36 (+3.03), SQNM: 2.95 (+0.11), A: 39.40 (+0.48), DHR: 86.65 (+0.91), HOLX: 38.71 (+0.75)
Coagulation Analyzer Market Expected to Reach $3.58 Billion by 2019, New Report Says
M2 - Wed May 27, 9:03AM CDT
Research and Markets (http://www.researchandmarkets.com/research/prc6rk/coagulationhemost) has announced the addition of the "Coagulation/Hemostasis Analyzer Market by Product , Consumables, Test Type, Technology, End Users - Forecast to 2019" report to their offering. The global coagulation analyzers market is estimated to grow at a lower CAGR in developed countries; however, it is expected to witness high growth in emerging countries such as China, India, and Brazil in the next five years. Growth in the coagulation analyzers market is driven by factors such as increasing adoption of automated hemostasis instruments by diagnostics laboratories, development of high-throughput hemostasis analyzers, developments in high-sensitivity point-of-care coagulation analyzers, and introduction of technologically advanced hemostasis instruments. However, slow adoption of advanced hemostasis instruments in emerging economies and high cost of hemostasis analyzers are restraining the growth of this market. New product launches and expansions are the key strategies adopted by major players to strengthen their position in the global coagulation analyzer market. Moreover, strategies such as partnerships, agreements, collaborations, joint ventures, and acquisitions were also adopted by a significant number of market players to strengthen their product portfolios and expand their geographic presence. Key Topics Covered 1 Introduction 2 Research Methodology 3 Executive Summary 4 Market Overview 5 Industry Insights 6 Hemostasis/Coagulation Analyzer Market, By Product Type 6.1 Introduction 6.2 Clinical Laboratory Analyzers 6.3 Hemostasis Analyzers for Point-Of-Care Testing 7 Hemostasis/Coagulation Analyzer Market, By Type of Test 7.1 Introduction 7.2 Prothrombin Time (PT/INR) Testing Kits Market 7.3 ACTivated Clotting Time (ACT/APTT) Testing Kits Market 7.4 D Dimer Testing Kits Market 7.5 Fibrinogen Testing Kits Market 7.6 Others Testing Kits Market 8 Hemostasis/Coagulation Analyzer Market, By Technology 8.1 Introduction 8.2 Mechanical 8.3 Optical 8.4 Electrochemical 8.5 Ohers 9 Hemostasis/Coagulation Analyzer Market, By End Users 9.1 Introduction 9.2 Research Institutes 9.3 Diagnostic Laboratories 9.4 Standalone Hospitals 9.5 Other End Users 10 Coagulation Analyzer Market, By Geography 11 Competitive Landscape 12 Company Profile 13 Appendix Companies Mentioned - Alere - Diagnostica Stago - Helena Laboratories - Instrumentation Laboratory Werfen Group - International Technidyne Corporation - Nihon Kohden Corporation (Nihon Kohden) - Roche Diagnostics - Siemens Helathcare - Sysmex Corporation - Thermo Fisher Scientific For more information visit http://www.researchandmarkets.com/research/pr...tionhemost
2015 Strategies in the US Point-of-Care/POC Infectious Disease Testing Market
M2 - Tue May 26, 10:32AM CDT
Research and Markets (http://www.researchandmarkets.com/research/cs5s58/2015_strategies) has announced the addition of the "2015 Strategies in the US Point-of-Care/POC Infectious Disease Testing Market" report to their offering. This new 795-page report contains 61 tables, and provides a comprehensive analysis of the POC infectious disease testing market, including trends, dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and emerging opportunities for instrument and consumable suppliers. This report will help diagnostic product suppliers develop effective business, R&D and marketing strategies for the global POC infectious disease testing market. Companies Mentioned: - ADI/America Diagnostica - Abbott - Agilent Technologies - Becton Dickinson - bioMeriuex - Bio/Data - Biomerieux - Biosite/Inverness/Alere - Cepheid - Diagnostica Stago/Trinity Biotech - Diamedix - Diasorin - EKF Diagnostics - Eiken Chemical - Fujirebio/Innogenetics - Helena Laboratories - Hologic/Gen-Probe - Mackay Life Sciences - Matritech - Nihon Kohden - Ortho-Clinical Diagnostics - Polartechnics - Polymedco - Qiagen - Roche - Siemens - Sienco - Sysmex - Takara Bio - ThermoFisher - Tosoh - Tosoh - Wako - Wallac - Zycare/Alere For more information visit http://www.researchandmarkets.com/research/cs...strategies
A: 39.40 (+0.48), CPHD: 58.15 (+0.75), HOLX: 38.71 (+0.75)
MEA Defibrillators Market Expected To Reach an Estimated Value Of USD 347.8 Million By 2020, Growing at a CAGR of 7.6%
M2 - Fri May 22, 8:55AM CDT
Research and Markets (http://www.researchandmarkets.com/research/jrwr4s/defibrillators) has announced the addition of the "Defibrillators Market - Middle East and Africa Industry Analysis, Size, Volume, Share, Growth, Trends and Forecast 2014 - 2020 " report to their offering. Growing incidences of cardiovascular disease and increasing healthcare infrastructure in the Middle East and Africa are the major factors expected to boost the growth in demand for defibrillators in the region. However, despite an excellent market opportunity in the Middle East and Africa, lack of awareness pertaining to operating of a defibrillator during emergency and unfavorable government intervention to install automated external defibrillators (AEDs) in public places are the key restraints for the growth of market in the Middle East and Africa. Key Topics Covered 1 Introduction 2 Executive Summary 2.1 Market Snapshot: Middle East and Africa Defibrillators Market 3 Market Overview 3.1 Introduction 3.2 Market Dynamics 3.3 Porter's Five Forces Analysis 3.4 Value Chain Analysis 3.5 Regulatory Framework 3.6 Competitive Landscape 3.7 Market Attractiveness Analysis, by Country 4 MEA Defibrillators Market, By Product 4.1 Introduction 4.2 Advanced Life Support (ALS) Defibrillator 4.3 Automated External Defibrillator (AED) 5 MEA Defibrillators Market, By End-user 5.1 Introduction 5.2 Hospital 5.3 Public Access Defibrillation 5.4 Emergency Medical Services 5.5 Business Workplace 6 MEA Defibrillators Market, By Geography 7 Recommendations 7.1 Recommendations - Invest in Public Awareness Programs About Sudden Cardiac Arrest and Defibrillators - Focus on AEDs at Businesses and Workplaces - Continuous Product Development To Ensure Safety And Efficacy 8 Company Profiles Companies Mentioned - HeartSine Technologies - Nihon Kohden - Philips Healthcare - Physio-Control - Schiller - Welch Allyn - Zoll Medical For more information visit http://www.researchandmarkets.com/research/jr...brillators
Nihon Kohden Announces Educational Sessions at National Teaching Institute and Critical Care Exposition
Business Wire - Mon May 18, 11:08AM CDT
As part of its ongoing commitment to education and research, Nihon Kohden, a U.S. market leader in patient monitoring, sleep assessment, neurology and cardiology instrumentation solutions, today announced it will conduct educational sessions for attendees of the American Association of Critical-Care Nurses (AACN) National Teaching Institute (NTI) and Critical Care Exposition, which will be held May 18-21 in San Diego. The three 30-minute sessions, which will be held multiple times May 19-21 at the Nihon Kohden booth, are available free of charge, with attendees earning 0.5 CEU credits for each presentation.
Global Brain Computer Interface Market 2015 - Forecasts to 2020 for the $1.46 Billion Market
M2 - Wed May 13, 8:33AM CDT
Research and Markets (http://www.researchandmarkets.com/research/krhb95/global_brain) has announced the addition of the "Global Brain Computer Interface Market (Type, Application and Geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2013 - 2020" report to their offering. The Global Brain Computer Interface (BCI) market is expected to reach $1.46 billion by 2020, registering a CAGR of 11.5% during 2014-2020 A global rise in the count of brain disorders along with the increasing government funding to improve healthcare systems, would supplement the growth of this market. The non-invasive BCI technology accounted for about 85% of the total BCI market revenue in 2013, and demonstrate a steady growth in future, thus, eliminating the need to perform surgeries and implant BCI devices. Geographically, North America holds a major share in the BCI technology market due to high penetration of such technologies in this region. APAC is also a major contributor primarily to the vast computer gaming industry. The European region constitutes the third largest market and is expected to grow at a relatively higher CAGR during the forecast period. The European Commission is taking active measures for the population with motor disabilities. Key findings of the study: - The Global market for BCI would exhibit a steady growth owing to its increased adoption across key sectors such as healthcare and the gaming industry, during the forecast period (2014 - 2020). - The Invasive BCI technology market would grow at the fastest CAGR of 15.3% during 2014-2020. - Swift growth is expected in the smart home control applications segment due to high living standards in the North American region, especially across U.S. and Canada. - The Asia-Pacific market would foresee tremendous growth for BCI technology systems. The growth is also attributed to the stiff competition amongst the prominent market players leading to swift technological advances in the BCI systems. Players such as Emotiv, Inc., Advanced Brain Monitoring Inc. and Nihon Kohden Corporation are adopting a consistent development process of innovative products to penetrate the market and further enhance the overall revenues. Key Topics Covered: CHAPTER 1 INTRODUCTION CHAPTER 2 EXECUTIVE SUMMARY CHAPTER 3 MARKET OVERVIEW CHAPTER 4 GLOBAL BRAIN COMPUTER INTERFACE MARKET, BY TYPE CHAPTER 5 GLOBAL BRAIN COMPUTER INTERFACE MARKET BY, APPLICATION CHAPTER 6 GLOBAL BRAIN COMPUTER INTERFACE MARKET , BY GEOGRAPHY CHAPTER 7 COMPANY PROFILES - Nihon Kohden Corporation, - Mind Solutions Inc. - Advanced Brain Monitoring, Inc. - Quantum Applied Science and Research, Inc. - Cadwell Laboratories Inc. - OpenBCI - Cortech Solutions, Inc. - Neurosky, Inc - Emotiv, Inc - Guger Technologies OEG For more information visit http://www.researchandmarkets.com/research/kr...obal_brain
European Sleep Apnea Devices Market, by Segment, and Sleep Apnea Therapeutic Devices - Forecast to 2019
M2 - Wed May 06, 6:13AM CDT
Research and Markets (http://www.researchandmarkets.com/research/bjqw72/european_sleep) has announced the addition of the "European Sleep Apnea Devices Market, by Segment (Sleep Apnea Diagnostic Devices (Home Sleep Testing, Respiratory Polygraphs, Actigraphy Systems) and Sleep Apnea Therapeutic Devices (Pap Devices, Oxygen Devices, Airway Clearance Systems)-Forecast to 2019" report to their offering. The European sleep apnea devices market is projected to grow at a CAGR of 16.0% from 2014 to 2019 Germany holds the largest share of the European sleep apnea devices market. This large share of the German segment is attributed to the various driving forces, such as the increasing prevalence of sleep disorders in this region, increasing awareness level among patients and caregivers, rising number of cases of cardiovascular disorders, and the availability of technologically advanced diagnostic and therapeutic devices. However, the inadequate reimbursement coverage and patient compliance are perceived to hinder the growth of this market in the coming years. The high costs associated with the diagnosis and treatment of sleep apnea also restrains the growth of devices market in this region. The research report classifies the European sleep apnea devices market on the basis of segment into sleep apnea therapeutic devices and sleep apnea diagnostic devices. The sleep apnea therapeutic devices is further segmented based on types into home sleep testing/portable monitoring, sleep labs, respiratory polygraphs, two channel screening devices, single channel screening devices, and actigraphy systems. Similarly, the sleep apnea therapeutic devices market is segmented based on the types into Positive Airway Pressure (PAP) devices, masks, adaptive servo-ventilation, airway clearance systems, oxygen devices, and oral appliances. The PAP devices segment is the largest contributor in the therapeutic devices market. Moreover, the therapeutic devices segment is the largest contributor to the overall European sleep apnea devices market, having accounted for a share of 58.1% in 2014. Further, the European sleep apnea devices market is segmented based on the major countries of the region, such as Germany, France, the U.K., Italy, Spain, and the Rest of Europe (RoE). Germany is the largest market for sleep apnea devices in Europe. It accounted for a share of 27.9% of the European sleep apnea devices market in 2014. The major factors contributing to its dominance are the increasing prevalence of sleep disorders, rising awareness among patients and caregivers, and availability of advanced diagnosis and therapy options. France is the second-largest market in Europe and is projected to grow at a CAGR of 16.6% from 2014 to 2019. The U.K. houses the fastest-growing segment of the European sleep apnea devices market, and is projected to grow at the fastest CAGR from 2014 to 2019. The rising research & development activities pertaining to sleep disorders, rising obesity rates, and increasing awareness levels among patients and caregivers, are some of the factors expected to drive the growth of the European sleep apnea devices market in the coming years. Companies Mentioned - Ambulatory Monitoring, Inc. - BMC Medical Co., Ltd. - Carefusion Corporation - Compumedics Limited - Devilbiss Healthcare - Fisher and Paykel Healthcare Ltd. - Itamar Medical, Ltd. - Natus Medical, Inc. - Nihon Kohden - Nonin Medical - Philips Respironics (Subsidiary of Philips Healthcare Ltd.) - Resmed, Inc. - Somnomedics Gmbh - Weinmann Medical Devices Gmbh & Co. Kg For more information visit http://www.researchandmarkets.com/research/bj...pean_sleep
BABY: 42.30 (+1.11)
North American Automated External Defibrillator (AED) Market 2015 - Forecast to 2019 for Semi-Automated External Defibrillators and Fully-Automated External Defibrillators
M2 - Wed Apr 29, 10:30AM CDT
Research and Markets (http://www.researchandmarkets.com/research/3mpnvr/north_american) has announced the addition of the "North American Automated External Defibrillator (AED) Market by Product, by End-User - Forecast to 2019" report to their offering. The North American automated external defibrillator (AED) market is estimated to grow at a CAGR of 6.8% from 2014 to 2019. The U.S. held a larger share of the automated external defibrillator (AED) market with about 89.9% in 2013, followed by Canada. The North American automated external defibrillator (AED) market holds high potential for growth in future, due to a number of forces that favor this market. These include the rising incidences of cardiovascular diseases and sudden cardiac arrest (SCA), increasing awareness of SCA and the life-saving potential of AEDs, and an implementation of public access defibrillation programs in various countries. In this report, the North American automated external defibrillator (AED) market is broadly classified on the basis of product types, pricing of the equipment, and end-users. The products segment is classified into semi-automated external defibrillators and fully-automated external defibrillators. Based on end-users, the automated external defibrillator (AED) market is categorized into public facilities, hospitals, pre-hospitals, homecare & nursing homes, and others. Geographically, the market is divided into two countries, namely the U.S. and Canada. The U.S. is estimated to command the largest share of 89.9% of the North American automated external defibrillator (AED) market in 2013, followed by Canada. Canada is estimated to grow at a CAGR of 6.8% from 2014 to 2019. The U.S. forms the largest market for AEDs with about 200,000 units sold annually for public use. Strong competition in the U.S. market has brought about a significant decrease in AED costs. Following the enforcement of federal law that necessitates the installation of public access defibrillators (PAD), a large number of AEDs have been installed at public places in the U.S., resulting in growth in this region. The report has profiled the leading players of this market along with their developments (new product launches & partnerships, agreements, collaborations, and joint ventures) over the past few years and strategies adopted by them to sustain and strengthen their position in the North American automated external defibrillator (AED) market. Philips Healthcare (the Netherlands), Cardiac Science Corporation (U.S.), ZOLL Medical Corporation (U.S.), Physio-Control, Inc. (U.S.), NIHON KOHDEN CORPORATION (Japan), Defibtech, LLC (U.S.), and HeartSine Technologies, Inc. (U.S.) are some of the key players engaged in this market. For more information visit http://www.researchandmarkets.com/research/3m...h_american
Sleep Apnea Devices Market by Segments (Sleep Apnea Therapeutic Devices, Sleep Apnea Diagnostic Devices) - Global Forecast to 2019
M2 - Thu Apr 23, 9:08AM CDT
Research and Markets (http://www.researchandmarkets.com/research/lnxd5m/sleep_apnea) has announced the addition of the "Sleep Apnea Devices Market by Segments (Sleep Apnea Therapeutic Devices, Sleep Apnea Diagnostic Devices) - Global Forecast to 2019" report to their offering. The global sleep apnea devices market is expected to grow at a CAGR of 16.6% during the forecast period of 2014 to 2019. North America is the largest market in the global sleep apnea devices market, with a market share of 51.8% as of 2013, followed by Europe and Asia. The largest share of the North American segment is associated with various driving forces, such as the increasing patient pool of sleep apnea in this region, increasing awareness level among patients and caregivers, and the availability of technologically advanced diagnostic and therapeutic devices. It is estimated that approximately 4% of men and 2% of women suffer from Obstructive Sleep Apnea (OSA) globally. Also, the rising prevalence of comorbidities (such as drug-resistant hypertension, congestive heart failure, Type 2 diabetes, and stroke, among others) ensures that the global sleep apnea patient pool will grow in the coming years. However, the inadequate reimbursement coverage and patient compliance are perceived to hinder the growth of this market during the forecast period, 2014 to 2019. In this report, the global sleep apnea devices market is broadly classified on the basis of segments, namely sleep apnea therapeutic devices and sleep apnea diagnostic devices. The sleep apnea therapeutic devices is further segmented based on types, into home sleep testing/portable monitoring, sleep labs, respiratory polygraphs, two-channel screening devices, single channel screening devices, and actigraphy systems. Similarly, the sleep apnea therapeutic devices market is segmented based on types, into Positive Airway Pressure (PAP) devices, masks, adaptive servo-ventilation, airway clearance systems, oxygen devices, and oral appliances. PAP devices segment is the highest contributor in the therapeutic devices market. Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Market Overview 5 Global Sleep Apnea Devices Market, By Type 6 Global Sleep Apnea Market, By Geography 7 Global Sleep Apnea Devices Market: Competitive Landscape 8 Sleep Apnea Devices Market, By Company - Advanced Brain Monitoring,Inc., - Ambulatory Monitoring, Inc. - Bmc Medical Co., Ltd. - Cadwell Laboratories, Inc. - Carefusion Corporation - Clevemed - Compumedics Limited - Fisher And Paykel Healthcare Ltd. - Itamar Medical, Ltd. - Natus Medical, Inc. - Nihon Kohden - Nonin Medical - Novasom - Philips Respironics (Subsidiary Of Philips Healthcare Ltd.) - Resmed, Inc. - Weinmann Medical Devices Gmbh & Co. Kg For more information visit http://www.researchandmarkets.com/research/ln...leep_apnea
BABY: 42.30 (+1.11)
Global Defibrillators Market 2015-2019 - Implantable Cardioverter Defibrillator (Single & Dual Chamber, CRT-D, & S-ICD) and External (Monitor/Defibrillator, AED, & Wearable)
M2 - Mon Apr 20, 4:12AM CDT
Research and Markets (http://www.researchandmarkets.com/research/w4vpdf/defibrillators) has announced the addition of the "Defibrillators Market by Product (Implantable Cardioverter Defibrillator (Single & Dual Chamber, CRT-D, & S-ICD) and External (Monitor/Defibrillator, AED, & Wearable)), by End User (Hospital, Pre-hospital, Public Access, & Home) - Global Forecast to 2019" report to their offering. The global defibrillator market is estimated to grow $12.9 billion by 2019, at a CAGR of 6.9% from 2014 to 2019. Factors such as development of technologically advanced defibrillator, rapid growth in aging population with high risk of target diseases, rising incidences of cardiovascular disease, growing focus of public and private organizations and key market players toward public access defibrillator, and increasing number of training and awareness programs across the globe are propelling the growth of the market. However, lack of awareness about sudden cardiac arrest, issues related to the use of defibrillator devices (external and implantable), and unfavorable healthcare reforms in the U.S. are restraining the growth of this market. In addition to this, the increasing pricing pressure on market players and frequent product recalls are the key challenges faced by market players in the market. On the basis of regions, this market is classified into North America, Europe, Asia-Pacific, and Rest of the World. In 2014, North America is expected to dominate the global defibrillators market. Growth of this region can be attributed to the technological advancements and product innovations, increasing number of public defibrillation programs, rising prevalence of obesity, and rising focus of key players to expand their business in the North American region. However, the Asia-Pacific market is expected to grow at the highest CAGR from 2014 to 2019, due to factors such as rapidly increasing aging population, growing focus of multinational companies on emerging markets, improving and modernizing healthcare infrastructure, and huge burden of cardiovascular disease in this region. Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Premium Insights 5 Market Overview 6 Industry Trends 7 Global Defibrillators Market, By Product 8 Global Defibrillators Market, By End User 9 Defibrillator Market, By Region 10 Competitive Landscape 11 Company Profiles - Biotronik Se & Co.KG - Boston Scientific Corporation - Cardiac Science Corporation (A Subsidiary of Opto Circuits India Limited) - Heartsine Technologies, Inc. - Medtronic, Inc. - Nihon Kohden Corporation - Philips Healthcare (A Division of Koninklijke Philips N.V.) - Physio-Control, Inc. - ST. Jude Medical, Inc. - Sorin Group - Zoll Medical Corporation (A Subsidiary of Asahi Kasei Corporation) For more information visit http://www.researchandmarkets.com/research/w4...brillators
BSX: 17.60 (+0.15), MDT: 74.37 (+1.28), STJ: 75.33 (+0.79)
Global Sleep Apnea Diagnostic and Therapeutic Devices Market 2015-2019
M2 - Wed Apr 15, 4:23AM CDT
Research and Markets (http://www.researchandmarkets.com/research/8w259s/global_sleep) has announced the addition of the "Global Sleep Apnea Diagnostic and Therapeutic Devices Market 2015-2019" report to their offering. The Global Sleep Apnea Diagnostic and Therapeutic Devices market to grow at a CAGR of 8.16 percent over the period 2014-2019. Sleep apnea is a common sleeping disorder that breaks breath many times during sleep. OSA is the common type of sleep apnea, and it causes snoring, when the soft tissue in the back of the throat relaxes during sleep and blocks the airway. Sleep apnea symptoms includes morning headaches, waking up frequently to urinate, and dry mouth and sore in the morning. Sleep apnea diagnostic devices such PSG, actigraphy systems, and pulse oximeters are used for the screening of sleep apnea, while positive airway pressure and oral appliances are used for sleep apnea therapy. High adoption of home diagnostics for diagnosis of sleep apnea is a key trend ibn this market. Home diagnostics are convenient and cost-effective when compared to in-lab sleep tests and therefore are expected to propel the market growth. According to the report, high prevalence of sleep apnea disorder in people worldwide is a major driver in the market. The disorder is common in both adults and children and can result in hypertension, stroke, type II diabetes or adult onset diabetes, weight gain, impotence and cardiovascular diseases. Further, the report states that lack of patient compliance is a key challenges in the market. Discomfort coupled with nosebleeds, anxiety, appliance leaking, claustrophobia and nasal stuffiness contribute to non-compliance when using CPAP or BiPAP devices. Key Vendors - Fisher & Paykel Healthcare - Philips Healthcare - ResMed Other Prominent Vendors - Apnex Medical - Briggs Healthcare - Bunnell - Cadwell Laboratories - Carefusion - Clement Clarke International - Cleveland Medical Devices - Compumedics - Dehaier Medical Systems - DeVilbiss Healthcare - Drager Medical - Embla Systems - GE Healthcare - Hamilton Medical - ImThera Medical - Invacare Corporation - Itamar Medical - Natus Medical - Nihon Kohden - Salter Labs - Teleflex Medical - Ventus Medical - Weinmann Gerate fur Medizin - Zephyr Sleep Technologies Key Topics Covered: - Executive Summary - List of Abbreviations - Scope of the Report - Market Research Methodology - Introduction - Types of Sleep Apnea - Disease Linked with the Sleep Apnea - Symptoms Associated with Sleep Apnea - Market Landscape - Global Sleep Apnea Diagnostic and Therapeutic Devices Market - Geographical Segmentation - Buying Criteria - Market Growth Drivers - Drivers and their Impact - Market Challenges - Impact of Drivers and Challenges - Market Trends - Trends and their Impact - Vendor Landscape - Key Vendor Analysis For more information visit http://www.researchandmarkets.com/research/8w...obal_sleep
BABY: 42.30 (+1.11), DHRM: 2.01 (unch), IVC: 20.62 (+0.25)
Nihon Kohden Names Dr. Wilson Constantine CEO of North America
Business Wire - Tue Apr 14, 6:00AM CDT
Nihon Kohden, a U.S. market leader in patient monitoring, sleep assessment, neurology and cardiology instrumentation solutions, has appointed Dr. Wilson P. Constantine the new chief executive officer of Nihon Kohden America. Constantine, who joined the company's U.S. operations as chief operating officer in September 2014, was named CEO as part of a reorganization that will allow the company to remain ahead of the needs of the rapidly changing U.S. healthcare market. He succeeds Fumio Izumida, who led the company through solid double digit growth between 2010 and 2015.
